Imipenem and cilastatin and Weight decreased - a phase IV clinical study of FDA data

Summary:

Weight decreased is reported as a side effect among people who take Imipenem and cilastatin (cilastatin sodium; imipenem), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Pyridoxine, and have Pulmonary tuberculosis.

The phase IV clinical study analyzes which people have Weight decreased when taking Imipenem and cilastatin. It is created by eHealthMe based on reports of 2,093 people who have side effects when taking Imipenem and cilastatin from the FDA, and is updated regularly.

What is Imipenem and cilastatin?

Imipenem and cilastatin has active ingredients of cilastatin sodium; imipenem. eHealthMe is studying from 2,097 Imipenem and cilastatin users. Check the latest studies of Imipenem and cilastatin.

What is Weight decreased?

Weight decreased is found to be associated with 3,393 drugs and 4,746 conditions by eHealthMe. Check the latest studies of Weight decreased.

On Jul, 17, 2026

2,093 people reported to have side effects when taking Imipenem and cilastatin.
Among them, 16 people (0.76%) have Weight decreased.

Could Imipenem and cilastatin cause Weight decreased?

Among these 16 people:

How long have people been on Imipenem and cilastatin when they have Weight decreased? *

What is the gender of people who have Weight decreased when taking Imipenem and cilastatin? *

female: 43.75 %
male: 56.25 %

What is the age of people who have Weight decreased when taking Imipenem and cilastatin? *

What are other drugs people take besides Imipenem and cilastatin? *

What are other side effects people have besides Weight decreased? *

Nausea (feeling of having an urge to vomit): 9 people, 56.25%
Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 6 people, 37.50%
Nausea And Vomiting: 4 people, 25.00%
Cough: 4 people, 25.00%
Liver Function Test Abnormal: 4 people, 25.00%
Dyspnea (difficult or laboured breathing): 4 people, 25.00%
General Physical Health Deterioration (weak health status): 3 people, 18.75%
Unresponsive To Stimuli: 3 people, 18.75%
Movement - Uncoordinated: 3 people, 18.75%
Dizziness: 3 people, 18.75%

What are the existing conditions these people have? *

Pulmonary Tuberculosis (lungs tuberculosis): 4 people, 25.00%
Cystic Fibrosis (disease of the secretary glands): 2 people, 12.50%
Pain: 2 people, 12.50%
Chronic Myeloid Leukaemia (long lasting type of cancer that starts in the blood-forming cells of the bone marrow and invades the blood): 2 people, 12.50%
Tuberculosis (a bacterial infection by mycobacterium tuberculosis): 1 person, 6.25%
Fever: 1 person, 6.25%
Febrile Neutropenia (fever with reduced white blood cells): 1 person, 6.25%
Discomfort: 1 person, 6.25%
Cystic Fibrosis Lung (fibrosis with cyst in the lung): 1 person, 6.25%
Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 1 person, 6.25%

* Approximation only. Some reports may have incomplete information.

Do you take Imipenem and cilastatin and have Weight decreased?

- Check whether Weight decreased is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Imipenem and cilastatin:

Imipenem and cilastatin (2,097 reports)

Weight decreased treatments and more:

Weight decreased (364,522 reports)

Browse all side effects of Imipenem and cilastatin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Weight decreased:

Weight decreased (3,393 drugs)

Browse all the conditions that are associated with Weight decreased:

Weight decreased (4,746 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on cilastatin sodium; imipenem (the active ingredients of Imipenem and cilastatin) and Imipenem and cilastatin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.